Erik Jørgensen

14.6k citations

195 papers · 9.0k indexed · 4 hit papers · h-index 44

Impact in

Cardiology and Cardiovascular Medicine top 0.2%
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiovascular Function and Risk Factors
Radiology, Nuclear Medicine and Imaging top 0.5%
- Cardiac Imaging and Diagnostics

Papers in

Cardiology and Cardiovascular Medicine 98
- Acute Myocardial Infarction Research 56
- Cardiovascular Function and Risk Factors 15
Radiology, Nuclear Medicine and Imaging 57
- Cardiac Imaging and Diagnostics 56

Co-authors: Henning Kelbæk Steffen Helqvist Jens Kastrup Kari Saunamäki Thomas Engstrøm Peter Clemmensen Lene Holmvang Lars Køber
Journals: EuroIntervention (15 papers)Resuscitation (11 papers)American Heart Journal (10 papers)Journal of the American College of Cardiology (9 papers)European Heart Journal (8 papers)
Partner nations: Denmark Sweden Germany

In The Last Decade

Erik Jørgensen

183 papers receiving 8.7k citations

Hit Papers

align trajectories log scale

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial 2015 · 586 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 The Lancet
2011 European Heart Journal
2011 European Heart Journal
2005 European Heart Journal

Peers

Countries citing papers authored by Erik Jørgensen

Since Specialization

Citations

This map shows the geographic impact of Erik Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jørgensen more than expected).

Fields of papers citing papers by Erik Jørgensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jørgensen. The network helps show where Erik Jørgensen may publish in the future.

Co-authors

The 25 scholars most cited alongside Erik Jørgensen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Erik Jørgensen Line = papers co-authored together Erik Jørgensen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acute kidney injury – A frequent and serious complication after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction PLoS ONE ·D. Balasubramaniam, Christian Cabrera Kang, Hedvig Andersson, Thomas Engstrøm, Peter Clemmensen, Steffen Helqvist, Erik Jørgensen, Henning Kelbæk, Frants Pedersen, Kari Saunamäki, Jacob Lønborg, Lene Holmvang	2019	17
2	Bleeding Events After ST-segment Elevation Myocardial Infarction in Patients Randomized to an All-comer Clinical Trial Compared With Unselected Patients The American Journal of Cardiology ·Golnaz Sadjadieh, Thomas Engstrøm, Dan Eik Høfsten, Steffen Helqvist, Lars Køber, Frants Pedersen, Peter Nørkjær Laursen, Hedvig Andersson, Lars Nepper‐Christensen, Peter Clemmensen, Rikke Sørensen, Erik Jørgensen, Kari Saunamäki, Hans-Henrik Tilsted, Henning Kelbæk, Lene Holmvang	2018	5
3	Comparison of Outcome of Patients With ST-Segment Elevation Myocardial Infarction and Complete Versus Incomplete ST-Resolution Before Primary Percutaneous Coronary Intervention The American Journal of Cardiology ·Jacob Lønborg, Henning Kelbæk, Lene Holmvang, Steffen Helqvist, Niels Vejlstrup, Erik Jørgensen, Kari Saunamäki, Nadia Dridi, Lene Kløvgaard, Anne Kaltoft, Hans Erik Bøtker, Jens Flensted Lassen, Peter Clemmensen, Christian Juhl Terkelsen, Thomas Engstrøm	2016	9
4	Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction JACC: Cardiovascular Interventions ·Lene Holmvang, Henning Kelbæk, Anne Kaltoft, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans Erik Bøtker, Kari Saunamäki, Lars Romer Krusell, Erik Jørgensen, Hans–Henrik Tilsted, Evald Høj Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian Juhl Terkelsen, Steffen Helqvist	2013	31
5	Autotransplantation of mesenchymal stromal cells from bone-marrow to heart in patients with severe stable coronary artery disease and refractory angina — Final 3-year follow-up International Journal of Cardiology ·Anders Bruun Mathiasen, Mandana Haack‐Sørensen, Erik Jørgensen, Jens Kastrup	2013	48
6	Impact of system delay on infarct size, myocardial salvage index, and left ventricular function in patients with ST-segment elevation myocardial infarction American Heart Journal ·Jacob Lønborg, Mikkel Malby Schoos, Henning Kelbæk, Lene Holmvang, Jacob Steinmetz, Niels Vejlstrup, Erik Jørgensen, Steffen Helqvist, Kari Saunamäki, Hans Erik Bøtker, Won Yong Kim, Christian Juhl Terkelsen, Peter Clemmensen, Thomas Engstrøm	2012	49
7	Use of performance curves in estimating number of procedures required to achieve proficiency in coronary angiography Catheterization and Cardiovascular Interventions ·G. Ponce Adams, Erik Jørgensen, Takehiro Taziri, Lars Lönn, Charlotte Ringsted	2011	11
8	Long-Term Outcome After Drug-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction Journal of the American College of Cardiology ·Anne Kaltoft, Henning Kelbæk, Leif Thuesen, Jens Flensted Lassen, Peter Clemmensen, Lene Kløvgaard, Thomas Engstrøm, Hans Erik Bøtker, Kari Saunamäki, Lars Romer Krusell, Erik Jørgensen, Hans-Henrik Tilsted, Evald Høj Christiansen, Jan Ravkilde, Lars Køber, Klaus F. Kofoed, Christian Juhl Terkelsen, Steffen Helqvist	2010	58
9	Long-Term Outcome in Patients Treated With Sirolimus-Eluting Stents in Complex Coronary Artery Lesions Journal of the American College of Cardiology ·Henning Kelbæk, Lene Kløvgaard, Steffen Helqvist, Jens Flensted Lassen, Lars Romer Krusell, Thomas Engstrøm, Hans Erik Bøtker, Erik Jørgensen, Kari Saunamäki, Hugh Burchett, Per Thayssen, Anders Galløe, Gunnar V.H. Jensen, Leif Thuesen	2008	40
10	Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial EuroIntervention ·Steffen Helqvist, Henning Kelbæk, Leif Thuesen, Lene Kløvgaard, Lars Romer Krusell, Erik Jørgensen, Hans Erik Bøtker, Gunnar V.H. Jensen, Jens Flensted Lassen, Per Thayssen, Anders Galløe, Kari Saunamäki	2007	3
11	Mobilization of haematopoietic and non-haematopoietic cells by granulocyte-colony stimulating factor and vascular endothelial growth factor gene therapy in patients with stable severe coronary artery disease Scandinavian Cardiovascular Journal ·Yongzhong Wang, R Ripa, Erik Jørgensen, Birger Hesse, 伸治藤山, Jens Kastrup	2007	6
12	Velferd hos kalver i kaldfjøs BIBSYS Brage (BIBSYS (Norway)) ·Inger Hansen, Erik Jørgensen	2006	1
13	Guidelines for Percutaneous Coronary Interventions European Heart Journal ·Sigmund Silber, Per Albertsson, Francisco Fernández‐Avilés, Paolo G. Camici, Antonio Colombo, Christian W. Hamm, Erik Jørgensen, Jean Marco, Florian Scholl, Witold Rużyłło, Philip Urban, Gregg W. Stone, William Wijns Hit paper breakdown →	2005	1134
14	The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) Trial Journal of the American College of Cardiology ·Henning Kelbæk, Leif Thuesen, Steffen Helqvist, Lene Kløvgaard, Erik Jørgensen, Hugh Burchett, Kari Saunamäki, Lars Romer Krusell, Gunnar V.H. Jensen, Hans Erik Bøtker, Jens Flensted Lassen, Henning Andersen, Per Thayssen, Anders Galløe, Frances Kiefer	2005	76
15	Safety of Bone Marrow Stem Cell Mobilization Induced by Granulocyte-Colony Stimulating Factor: 30 Days’ Blinded Clinical Results from the Stem Cells in Myocardial Infarction (STEMMI) Trial R Ripa, Yongzhong Wang, Erik Jørgensen, Hans Erik Johnsen, Peer Grande, Jens Kastrup	2005	11
16	Low restenosis rate of the NIR coronary stent: Results of the Danish multicenter stent study (DANSTENT)—a randomized trial comparing a first-generation stent with a second-generation stent American Heart Journal ·Erik Jørgensen, Henning Kelbæk, Steffen Helqvist, Gunnar V.H. Jensen, Kari Saunamäki, Jens Kastrup, Jan Kyst Madsen, Lene Kløvgaard, Leif Thuesen, Anton Boel Villadsen, Evi S. van der Linden, Johan H. C. Reiber	2003	28
17	[Yield of a coronary arteriography database. A study of 5.536 registrations at the cardiologic laboratory, Rigshospitalet]. PubMed ·Jan Bech, Jan Kyst Madsen, Erik Jørgensen, R. Videbæk, Christian Tuxen, Steffen Helqvist, J Launbjerg, Bente Kühn Madsen	2002	1
18	Intramyocardial Injection of Genes with a Novel Percutaneous Technique: Initial Safety Data of the Euroinject One Study Jens Kastrup, Erik Jørgensen, Viktor Drvota, Leif Thuesen, Hans Erik Bøtker, Mason Jt, Dietmar Glogar, Andreas Rück, Khalid B. Islam, Christer Sylvén	2001	7
19	Prediction of neurological outcome after cardiopulmonary resuscitation Resuscitation ·Erik Jørgensen, Søren Holm	1999	15
20	Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Malkasian Gd, Decker Dg, Erik Jørgensen, Edmonson Jh	1977	30

About Erik Jørgensen

Erik Jørgensen is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Genetics, Emergency Medicine and Surgery, having authored 195 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cardiac Imaging and Diagnostics (56 papers), Coronary Interventions and Diagnostics (56 papers), Acute Myocardial Infarction Research (56 papers), Mesenchymal stem cell research (23 papers), Cardiac Arrest and Resuscitation (18 papers), Traumatic Brain Injury and Neurovascular Disturbances (16 papers), Cardiovascular Function and Risk Factors (15 papers) and Tissue Engineering and Regenerative Medicine (14 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.9k citations), Radiology, Nuclear Medicine and Imaging (2.6k citations), Emergency Medicine (1.1k citations), Surgery (4.3k citations) and Genetics (1.0k citations). Erik Jørgensen has collaborated with scholars based in Denmark, Sweden and Germany. Frequent co-authors include Henning Kelbæk, Steffen Helqvist, Jens Kastrup, Kari Saunamäki, Thomas Engstrøm, Peter Clemmensen, Lene Holmvang, Lars Køber, Anders Bruun Mathiasen and Mandana Haack‐Sørensen. Their work appears in journals such as EuroIntervention, Resuscitation, American Heart Journal, Journal of the American College of Cardiology and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact